What to watch with VKORC1 and menopause?

VKORC1 is a key gene in vitamin K recycling, affecting coagulation and bone health. During menopause, cardiovascular risk and osteoporosis increase. Variants in VKORC1 (e.g., rs9923231) alter vitamin K sensitivity and can significantly impact warfarin dosing. However, direct studies linking VKORC1 to menopause-specific outcomes are scarce. The evidence is thus mechanistic: the connection is biologically plausible but not confirmed by large human trials. Women in menopause with VKORC1 variants should pay attention to bone density, as vitamin K plays a role in bone metabolism. Additionally, if on vitamin K antagonists (e.g., warfarin), close INR monitoring is essential. A DNA test alone cannot replace blood work. Beware of overblown claims in personalized medicine: the effect size of single VKORC1 variants is moderate and overshadowed by diet, hormones, and other factors.